Aries Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.06M Buy
5,085
+110
+2% +$44.6K 0.54% 46
2025
Q1
$2.48M Buy
4,975
+261
+6% +$130K 0.67% 40
2024
Q4
$2.45M Sell
4,714
-115
-2% -$59.8K 0.68% 36
2024
Q3
$2.99M Sell
4,829
-82
-2% -$50.7K 0.82% 31
2024
Q2
$2.72M Sell
4,911
-30
-0.6% -$16.6K 0.86% 31
2024
Q1
$2.87M Hold
4,941
0.93% 27
2023
Q4
$2.62M Buy
4,941
+1
+0% +$531 0.94% 27
2023
Q3
$2.41M Buy
4,940
+127
+3% +$62K 0.94% 28
2023
Q2
$2.51M Sell
4,813
-118
-2% -$61.6K 0.97% 29
2023
Q1
$2.84M Sell
4,931
-122
-2% -$70.3K 1.17% 22
2022
Q4
$2.78M Sell
5,053
-12
-0.2% -$6.61K 1.2% 21
2022
Q3
$2.6M Buy
5,065
+110
+2% +$56.5K 1.15% 22
2022
Q2
$2.69M Buy
+4,955
New +$2.69M 1.22% 21
2022
Q1
Sell
-4,755
Closed -$3.17M 204
2021
Q4
$3.17M Buy
4,755
+78
+2% +$52K 1.21% 19
2021
Q3
$2.67M Buy
4,677
+17
+0.4% +$9.71K 1.13% 24
2021
Q2
$2.35M Buy
4,660
+40
+0.9% +$20.2K 1.01% 27
2021
Q1
$2.21M Buy
4,620
+425
+10% +$203K 0.99% 28
2020
Q4
$2.15M Sell
4,195
-64
-2% -$32.8K 1.07% 26
2020
Q3
$1.88M Buy
4,259
+45
+1% +$19.9K 1.07% 26
2020
Q2
$1.53M Buy
4,214
+163
+4% +$59.1K 0.93% 30
2020
Q1
$1.17M Buy
4,051
+15
+0.4% +$4.31K 0.89% 34
2019
Q4
$1.31M Sell
4,036
-60
-1% -$19.5K 0.8% 35
2019
Q3
$1.16M Sell
4,096
-30
-0.7% -$8.51K 0.77% 37
2019
Q2
$1.24M Sell
4,126
-30
-0.7% -$9.02K 0.87% 34
2019
Q1
$1.14M Sell
4,156
-113
-3% -$30.9K 0.85% 37
2018
Q4
$955K Buy
4,269
+45
+1% +$10.1K 1.01% 35
2018
Q3
$1.03M Hold
4,224
0.93% 33
2018
Q2
$991K Buy
4,224
+90
+2% +$21.1K 0.92% 33
2018
Q1
$890K Buy
4,134
+60
+1% +$12.9K 0.86% 38
2017
Q4
$870K Buy
+4,074
New +$870K 0.8% 38